Search Results

GPCR University Course Attendee Ready to gain a competitive advantage?

GPCR University Course Attendee Dr.

License Agreement in Diabetes and Metabolic Diseases Sosei Heptares Enters R&D Agreements with the University Inversago Pharma Doses First Patient in Phase 2 Trial of INV-202, an Oral, Peripherally-acting CB1 Inverse

GPCR University We are excited to announce the dates for our upcoming courses led by Dr.

GPCR University We're thrilled to announce that Dr.

GPCR Podcast, we sit down with Alessandro Nicoli, from the Technical University of Munich, to discuss

Andrew Hopkins, Exscientia's CEO, will speak at the University of Chicago's Distinguished Seminar Series

studied, revealing that different ligands can stabilize distinct receptor conformations, leading to diverse Glucagon-Like Peptide -1 Receptor Transducer Coupling, Signalling and Biased Agonism . 2023, Monash University

GPCR University live Zoom sessions hosted by Dr. Terry Kenakin.

” - DrGPCR University Course Attendee Get a competitive advantage—Join Dr.

GPCR University Exciting news!

Additionally, DMS is not universally applicable to all proteins; it struggles with proteins that lack of the technique, enabling more precise interpretations of how mutations affect protein function in diverse

Insights into GPCR Function Pro-phagocytic function and structural basis of GPR84 signaling Structural diversity of leukotriene G-protein coupled receptors Industry News Duke University Celebrates Nobel Prize Winner

GPCR University We are excited to announce that Dr. Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals CB1 receptor inverse

GPCR University live courses we are preparing for you in 2024.

GPCR University 🎥 Access to the recorded classes of GPCR Courses and talks from Symposia 💲 Discounted

GPCR University The wait is finally over!

GPCR University We are excited to announce that Dr.

Janicot, R., et al., Direct interrogation of context-dependent GPCR activity with a universal biosensor

Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554 Cardiff-based Antiverse raises €2.8M for its computational antibody drug discovery platform Antiverse identifies therapeutic

ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours A Conversation with Murat Tunaboylu, Antiverse

receptor MRGPRX1 Improved approaches to channel capacity estimation discover compromised GPCR signaling in diverse Presented At ENDO Novo Nordisk to Acquire Inversago Pharma GPCR Events, Meetings, and Webinars NEW Antiverse

(March 30, 2023) NEW Webinar - Antiverse: Engineering the Future of Drug Discovery (March 30, 2023) NEW

GPCR News  Let’s dive into the   Classified GPCR News from October 7th to 13th, 2024 Industry News Antiverse Computational Chemistry Postdoc in GPCR mechanosensing   Postdoctoral Position GPCR Activation and Signaling Diverse

Quarter and First Nine Months of 2024 Nasdaq debutante Septerna swells its IPO to $331m Nxera Pharma and Antiverse

Michel Bouvier received the title of Doctor Honoris Causa from the Université de Montpellier Domain Therapeutics